Increased Stromal-Cell-derived Factor 1 Enhances the Homing of Bone Marrow Derived Mesenchymal Stem Cells in Dilated Cardiomyopathy in Rats.

Zhou Yan-li,Zhang Hai-feng,Li Xin-li,Di Ruo-min,Yao Wen-ming,Li Dian-fu,Feng Jian-lin,Huang Jun,Cao Ke-jiang,Michael Fu

DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.2010.22.021

2010-01-01

Abstract:Background Stem cell transplantation has been shown to have beneficial effects on dilated cardiomyopathy However, mechanism for stem cell homing to cardiac tissue in dilated cardiomyopathy has not yet been elucidatedMethods Mesenchymal stem cells were obtained from rat bone marrow, expanded in vitro, and labeled with Tc-99m Cardiomyopathy model was induced by doxorubicin in rats Tc-99m labeled cells were infused into the left ventricles in cardiomyopathy and control rats Sixteen hours after injection, animals were sacrificed and different tissues were harvested to measure specific radioactivity By use of real-time polymerase chain reaction and immunohistochemistry, mRNA and protein expressions for stromal-cell-derived factor 1 in cardiac tissue were measuredResults Labeling efficiency of mesenchymal stem cells was (70 0 +/- 11 2)% Sixteen hours after mesenchymal stem cell transplantation, the heart-to-muscle radioactivity ratio was increased significantly in cardiomyopathy hearts as compared to control hearts Both mRNA and protein expressions of stromal-cell-derived factor 1 were up-regulated in cardiomyopathy hearts as compared with control heartsConclusion In dilated cardiomyopathy induced by doxorubicin up-regulated expression of stromal-cell-derived factor 1 in heart may induce mesenchymal stem cells home to the heart Chin Med J 2010,123(22) 3282-3287